Evidence map›Paper›PMID 41819809›Full record

ArticleOccupational and environmental medicine2026

Occupational exposure to chlorinated solvents and lung cancer: results of the SYNERGY case-control study.

Wenxin Wan, Roel Vermeulen, Lützen Portengen, Ann Olsson, Joachim Schüz, Wendy Bijoux, Wolfgang Ahrens, Christine Barul, Thomas Behrens, Thomas Brüning and 32 more

Abstract read
In one paragraph

Article in Occupational and environmental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors.

Wenxin Wan *Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.ORCID 0000-0002-1957-4034
Roel Vermeulen *Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.ORCID 0000-0003-4082-8163
Lützen PortengenInstitute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.
Ann OlssonInternational Agency for Research on Cancer (IARC/WHO), Lyon, France.ORCID 0000-0001-6498-2259
Joachim SchüzInternational Agency for Research on Cancer (IARC/WHO), Lyon, France.
Wendy BijouxInternational Agency for Research on Cancer (IARC/WHO), Lyon, France.
Wolfgang AhrensLeibniz Institute for Prevention Research and Epidemiology, Bremen, Germany.
Christine BarulUniversité de Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail), Pointe-à-Pitre, France.
Thomas BehrensInstitute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University (IPA), Bochum, Germany.
Thomas BrüningInstitute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University (IPA), Bochum, Germany.
Neil E CaporasoDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Dario ConsonniOccupational Health Unit, IRCCS Foundation Maggiore Policlinico Hospital, Milan, Italy.
Paul A DemersOccupational Cancer Research Centre, Ontario Health, Toronto, Ontario, Canada.
Eleonora FabianovaRegional Authority of Public Health, Banská Bystrica, Slovakia.
Guillermo Fernández-TardónHealth Research Institute of Asturias, University of Oviedo, ISPA and CIBERESP, Oviedo, Spain.
John FieldRoy Castle Lung Cancer Research Programme, Cancer Research Centre, University of Liverpool, Liverpool, UK.
Francesco ForastiereDepartment of Epidemiology-Regional Health Service, ASL Roma 1, Roma, Italy.
Lenka ForetovaDepartment of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
Calvin B GeNetherlands Organization for Applied Scientific Research, Utrecht, The Netherlands.
Per GustavssonInstitute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-2221-8599
Vladimir JanoutFaculty of Health Sciences, Palacky University Olomouc, Olomouc, Czech Republic.
Karl-Heinz JöckelInstitute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, Essen, Germany.
Stefan KarraschInstitute and Clinic for Occupational, Social and Environmental Medicine, University Hospital Munich, München, Germany.
Benjamin KendziaInstitute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University (IPA), Bochum, Germany.ORCID 0000-0002-8662-795X
Maria Teresa LandiDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Jolanta LissowskaDepartment of Cancer Epidemiology and Prevention, Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Dana MatesNational Institute of Public Health, Bucharest, Romania.
John McLaughlinUniversity of Toronto Dalla Lana School of Public Health, Toronto, Ontario, Canada.
Franco MerlettiDepartment of Medical Sciences, Cancer Epidemiology Unit, University of Turin, Turin, Italy.
Enrica MiglioreDepartment of Medical Sciences, Cancer Epidemiology Unit, University of Turin, Turin, Italy.
Tamás PándicsDirectorate for Laboratory and Methodology, National Centre for Public Health and Pharmacy, Budapest, Hungary.
Hermann PohlabelnLeibniz Institute for Prevention Research and Epidemiology, Bremen, Germany.
Loredana RadoïCESP Centre for Research in Epidemiology and Population Health, Epidemiology of Occupational and Social Determinants of Health, INSERM, Villejuif, France.
Lorenzo RichiardiDepartment of Medical Sciences, Cancer Epidemiology Unit, University of Turin, Turin, Italy.
Miriam SchejbalovaFirst Faculty of Medicine, Institute of Hygiene and Epidemiology, Charles University, Prague, Czech Republic.
Jack SiemiatyckiDepartment of Social and Preventive Medicine, University of Montreal, Montreal, Quebec, Canada.ORCID 0000-0002-9042-8582
Beata ŚwiątkowskaDepartment of Environmental Epidemiology, Nofer Institute of Occupational Medicine, Lodz, Poland.
Heinz-Erich WichmannInstitute of Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany.
David ZaridzeDepartment of Clinical Epidemiology, N.N. Blokhin National Research Centre for Oncology, Moscow, Russia.
Kurt StraifISGlobal, Barcelona, Spain.ORCID 0000-0003-1402-2406
Hans KromhoutInstitute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.ORCID 0000-0002-4233-1890
Susan PetersInstitute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands S.Peters@uu.nl.ORCID 0000-0001-5662-1971

Funding

Studies of Genetic and Environmental EpidemiologyZIACP101231 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI LANDI, MARIA · 2018 to 2025
$23.6M
Intramural NIH HHS ZIA CP101231NCI NIH HHS N02 CP001006
6 · The paper itself

Abstract

objectiveThe association between occupational exposure to chlorinated solvents and lung cancer remains inconclusive. This study investigated this relationship using data from the internationally pooled SYNERGY study.

methodsData from 14 case-control studies conducted in 13 European countries and Canada were pooled, including 28 048 participants (12 329 cases and 15 719 controls). Lifetime occupational exposure to chlorinated solvents was assessed using the ALOHA+job-exposure matrix. ORs and 95% CIs were estimated using unconditional logistic regression, adjusted for study centre, age, sex, smoking (pack-years and cessation), cumulative exposure to five occupational lung carcinogens (asbestos, hexavalent chromium, polycyclic aromatic hydrocarbons, respirable crystalline silica and diesel engine exhaust), cumulative benzene exposure and employment in high-risk occupations ('List A' jobs). Associations were estimated across categories of exposure levels, durations and analyses stratified by smoking status and lung cancer subtypes.

resultsWe found no evidence of an association between ever exposure to chlorinated solvents and lung cancer risk (OR 1.03; 95% CI 0.96 to 1.10). Among exposed individuals, a positive trend with cumulative exposure was observed (p=0.031), but not when non-exposed individuals were included (p=0.173). Positive trends were found with exposure duration (p=0.005 for exposed; p=0.048 overall); risks were modestly elevated (OR 1.11) in those exposed for 20 or more years. No increased risk was observed across smoking strata or lung cancer subtypes.

conclusionsThis pooled analysis provides limited evidence of an association between occupational exposure to chlorinated solvents and lung cancer, though exposure-response trends were noted among exposed individuals.

Indexed as

Hydrocarbons, ChlorinatedLung NeoplasmsOccupational DiseasesOccupational ExposureSolventsAdultAgedCanadaCarcinogensCase-Control StudiesEuropeFemaleHumansLogistic ModelsMaleMiddle AgedCarcinogensHydrocarbons, ChlorinatedSolventsCancerEpidemiologySolvents

Identifiers

PMID41819809
PMCPMC13271013

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.